Structures by: Szłyk E.
Total: 8
C27H43Cl2N8O0.5Pd
C27H43Cl2N8O0.5Pd
Journal of the Chemical Society, Dalton Transactions (2000) 6 867
a=10.7430(6)Å b=11.0134(5)Å c=14.1340(6)Å
α=75.342(4)° β=81.431(4)° γ=79.665(4)°
C31H22Ag2F10O4P2
C31H22Ag2F10O4P2
Dalton Trans. (2003) 17 3404-3410
a=25.079(5)Å b=13.725(3)Å c=20.382(4)Å
α=90.00° β=108.56(3)° γ=90.00°
((2,2'-bipyridine)silver(i)(Trifluoroacetate))
C24H16Ag2F6N4O4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 7 1823-1830
a=7.2330(10)Å b=14.942(3)Å c=12.034(2)Å
α=90.00° β=103.78(3)° γ=90.00°
(hemi(2,2'-bipyridine)silver(i)(pentafluorpropionate))
C8H4AgF5NO2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 7 1823-1830
a=13.5630(10)Å b=16.1960(10)Å c=10.4560(10)Å
α=90.00° β=113.530(10)° γ=90.00°
(tetra(2,2'-bipyridine)hexasilver(i)hexa(heptafluorbutyrate))
C64H32Ag6F41N8O12
Dalton transactions (Cambridge, England : 2003) (2010) 39, 7 1823-1830
a=16.476(3)Å b=29.367(6)Å c=17.436(3)Å
α=90.00° β=103.15(3)° γ=90.00°
Dichlorobispyridazinezinc(II)
C8H8Cl2N4Zn
Acta Crystallographica Section E (2004) 60, 9 m1270-m1272
a=8.0330(10)Å b=17.034(2)Å c=8.5310(10)Å
α=90.00° β=96.090(10)° γ=90.00°
5,7-diphenyl[1,2,4]triazolo[1,5-a]pyrimidine
C17H12N4
Acta Crystallographica Section C (1999) 55, 8 1337-1339
a=7.8427(12)Å b=10.2644(13)Å c=16.961(2)Å
α=90.00° β=90.00° γ=90.00°
Hexakis(1<i>H</i>-imidazole-κ<i>N</i>^3^)cobalt(III) tris(hexafluoridophosphate) hexahydrate
C18H24CoN123,3(F6P),6(H2O)
Acta Crystallographica Section E (2009) 65, 10 m1256-m1257
a=20.9911(13)Å b=20.9911(13)Å c=7.0156(9)Å
α=90.00° β=90.00° γ=120.00°